Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-07-19
1991-10-22
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514947, 514951, 514970, 514953, A61K 3702
Patent
active
050595873
ABSTRACT:
A nasal administration powder composition containing a physiologically active peptide as an active ingredient can be efficiently absorbed through nasal mucosa by the addition of a water-soluble organic acid as an absorption promoter. This composition may further contain a diluent. The water-soluble organic acid used as absorption promoter includes, for example, at least one of succinic acid, tartaric acid, citric acid, fumaric acid, maleic acid, malonic acid, glutaric acid, adipic acid, malic acid, L-glutamic acid, L-aspartic acid, gluconic acid and glucuronic acid.
REFERENCES:
patent: 4476116 (1984-10-01), Anik
patent: 4609640 (1986-09-01), Morishita
patent: 4690952 (1987-09-01), Kagatani
Mizuno Kimio
Sakakibara Hideo
Yamamoto Nakayuki
Moezie F. T.
Toyo Jozo company, Ltd.
LandOfFree
Physiologically active peptide composition for nasal administrat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Physiologically active peptide composition for nasal administrat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Physiologically active peptide composition for nasal administrat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-108545